ID
Bron
Verkorte titel
Aandoening
Osteoarthritis patients in who total knee replacement is planned
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The primary objective is to investigate the difference between the two groups in change from baseline in Oxford Knee Scores at 6 weeks after the surgery.
Onderzoeksopzet
6 weeks, 12 weeks and 6 months after surgery
Onderzoeksproduct en/of interventie
Daily supplementation of hydrolysed collagen (10g) or placebo (maltodextrin; 10g), for a period of 12 weeks. All supplements will be provided as flavoured powder drink products that can be dissolved in water.
Publiek
W. Klöpping
Wageningen 6700 AA
The Netherlands
+31 317 484277
ineke.klopping-ketelaars@wur.nl
Wetenschappelijk
W. Klöpping
Wageningen 6700 AA
The Netherlands
+31 317 484277
ineke.klopping-ketelaars@wur.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Planned for total knee replacement therapy
> 18 years old and mentally competent
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Current use (latest use one week or less before inclusion) of supplements (like glucosamine, chondroitin, green-lipped mussel, curcumin or blackcurrant leaf).
Diagnosed with Rheumatoid Arthritis
Medical history of renal insufficiency (eGRF<60ml)
Daily use of high doses NSAIDs in the 14 days before inclusion: Defined as higher than maintenance dose in the “farmacotherapeutisch kompas”.
Vegetarians
Childbearing potential
Inability to perform the functional tests due to other impairments than the knee that is to be replaced
Use of systemic corticosteroids
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL6290 |
| NTR-old | NTR6464 |
| CCMO | NL58987.081.16 |
| OMON | NL-OMON42856 |